Regional Medical Science Liaison – IBD Immunology

Merck; Providence (RI); On-site; USD 140,000 - 190,000; Full time

Job summary

Merck seeks a Regional Medical Scientific Director (MSL) in Inflammatory Bowel Disease Immunology to drive scientific exchange and align with strategic priorities. The role acts as a field medical liaison, delivering balanced information on approved, in-development, and investigator-sponsored studies while adhering to GMSA policies.

The MSL will liaise with national/regional scientific leaders to enhance understanding of therapeutic foundations and to support investigator-sponsored research and

Qualifications

• Credentialed medical professional (PhD, PharmD, DNP, MD) preferred.
• Experience engaging with scientific leaders and providing unbiased scientific information.

Responsibilities

• Develops professional relationships with national and regional SLs to share company-approved medical information.
• Conducts peer-to-peer scientific discussions and maintains a medical contact within the company.
• Addresses questions outside scope (e.g., grants) to appropriate resources per policy.
• Maintains knowledge of the scientific landscape within the Area of Interest for the therapeutic area.
• Initiates discussions with SLs/investigators to align research concepts with strategies.
• Recommends study sites and investigators for phase II–IV programs; supports SIVs and enrollment strategies.
• Protocol lead responsibilities in collaboration with GCTO or equivalents.

Skills

Scientific communication

Stakeholder engagement

Medical affairs liaison

GCP knowledge

Education

PhD

MD

PharmD

DNP

Job description

Merck seeks a Regional Medical Scientific Director (MSL) in Inflammatory Bowel Disease Immunology to drive scientific exchange and align with strategic priorities. The role acts as a field medical liaison, delivering balanced information on approved, in-development, and investigator-sponsored studies while adhering to GMSA policies.

The MSL will liaise with national/regional scientific leaders to enhance understanding of therapeutic foundations and to support investigator-sponsored research and